• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌。最致命的妇科恶性肿瘤。

Ovarian cancer. The most lethal gynecologic malignancy.

作者信息

Brucks J A

机构信息

Brigham and Women's Hospital, Boston, Massachusetts.

出版信息

Nurs Clin North Am. 1992 Dec;27(4):835-45.

PMID:1448359
Abstract

The need for the early detection of ovarian cancer continues to be one of the most important issues in women's health care. The overall 5-year survival rate for epithelial ovarian cancer remains approximately 30% and has not improved over the last three decades. The failure to improve the prognosis for women with ovarian cancer is directly attributable to the lack of an effective screening test for early-stage disease. It is hoped that with the study of those women at high risk, an appropriate screening method will be discovered. Nurses should become knowledgeable about the nature of ovarian cancer, should be able to identify the woman at familial risk, and should look at a symptomatic woman with a high degree of suspicion. As health educators, nurses can provide up-to-date information about Ca 125 serum tests and vaginal ultrasonography used to screen high-risk populations. Nurses must educate women about the importance of the pelvic examination. Historically, nurses are trained to view the patient holistically. Such a viewpoint will help to put together all of the pieces of a difficult puzzle.

摘要

卵巢癌的早期检测需求仍然是女性医疗保健中最重要的问题之一。上皮性卵巢癌的总体5年生存率仍约为30%,在过去三十年中并未得到改善。卵巢癌患者预后未能改善直接归因于缺乏针对早期疾病的有效筛查测试。希望通过对高危女性的研究,能发现合适的筛查方法。护士应了解卵巢癌的本质,能够识别有家族风险的女性,并应对有症状的女性高度怀疑。作为健康教育者,护士可以提供有关用于筛查高危人群的Ca 125血清检测和阴道超声检查的最新信息。护士必须教育女性盆腔检查的重要性。从历史上看,护士接受的培训是从整体上看待患者。这样的观点将有助于拼凑起难题的所有碎片。

相似文献

1
Ovarian cancer. The most lethal gynecologic malignancy.卵巢癌。最致命的妇科恶性肿瘤。
Nurs Clin North Am. 1992 Dec;27(4):835-45.
2
Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.妇科癌症筛查。外阴、阴道、子宫内膜和卵巢肿瘤。
Prim Care. 1992 Sep;19(3):607-20.
3
A comprehensive look at the early detection of ovarian cancer.对卵巢癌早期检测的全面审视。
Clin J Oncol Nurs. 2003 Jan-Feb;7(1):41-7. doi: 10.1188/03.CJON.41-47.
4
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
5
Screening and detection of ovarian cancer.卵巢癌的筛查与检测
J Midwifery Womens Health. 2005 Jan-Feb;50(1):51-4. doi: 10.1016/j.jmwh.2004.10.002.
6
Women's awareness of ovarian cancer risks and symptoms.女性对卵巢癌风险和症状的认识。
Am J Nurs. 2009 Sep;109(9):36-45; quiz 46. doi: 10.1097/01.NAJ.0000360309.08701.73.
7
Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.可溶性表皮生长因子受体(sEGFR/sErbB1)作为上皮性卵巢癌潜在的风险、筛查及诊断血清生物标志物。
Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):103-13.
8
Screening for ovarian cancer.
Biomed Pharmacother. 1988;42(9):589-96.
9
Epidemiology and screening of ovarian cancer.卵巢癌的流行病学与筛查
Obstet Gynecol Clin North Am. 1994 Mar;21(1):1-23.
10
Women and cancer.
AWHONNS Clin Issues Perinat Womens Health Nurs. 1993;4(2):287-301.

引用本文的文献

1
M2 macrophage-derived exosomal circTMCO3 acts through miR-515-5p and ITGA8 to enhance malignancy in ovarian cancer.M2 巨噬细胞来源的细胞外体 circTMCO3 通过 miR-515-5p 和 ITGA8 发挥作用,增强卵巢癌的恶性程度。
Commun Biol. 2024 May 16;7(1):583. doi: 10.1038/s42003-024-06095-8.
2
Role of radiomics as a predictor of disease recurrence in ovarian cancer: a systematic review.基于放射组学的卵巢癌疾病复发预测作用的系统综述。
Abdom Radiol (NY). 2024 Oct;49(10):3540-3547. doi: 10.1007/s00261-024-04330-8. Epub 2024 May 15.
3
Oncogenic Events Dictate the Types and Locations of Gynecological Malignancies Originating from Mesothelial and Müllerian-Derived Epithelial Cells.
致癌事件决定了源自间皮细胞和苗勒管来源上皮细胞的妇科恶性肿瘤的类型和位置。
Cancers (Basel). 2022 Feb 8;14(3):841. doi: 10.3390/cancers14030841.
4
The Cancer Stem Cell Niche in Ovarian Cancer and Its Impact on Immune Surveillance.卵巢癌中的癌症干细胞生态位及其对免疫监视的影响。
Int J Mol Sci. 2021 Apr 15;22(8):4091. doi: 10.3390/ijms22084091.
5
Single nucleotide polymorphism of transforming growth factor-β1 and interleukin-6 as risk factors for ovarian cancer.转化生长因子-β1和白细胞介素-6的单核苷酸多态性作为卵巢癌的危险因素
Cent Eur J Immunol. 2020;45(3):267-275. doi: 10.5114/ceji.2020.101242. Epub 2020 Nov 1.
6
Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells.钙通道作为卵巢癌干细胞的新型治疗靶点。
Int J Mol Sci. 2020 Mar 27;21(7):2327. doi: 10.3390/ijms21072327.
7
Effect of ovarian cancer ascites on SKOV-3 cells proteome: new proteins associated with aggressive phenotype in epithelial ovarian cancer.卵巢癌腹水对SKOV-3细胞蛋白质组的影响:上皮性卵巢癌中与侵袭性表型相关的新蛋白质
Proteome Sci. 2018 Feb 13;16:3. doi: 10.1186/s12953-018-0133-9. eCollection 2018.
8
Common variants in IL-1RN, IL-1β and TNF-α and the risk of ovarian cancer: a case control study.白细胞介素-1受体拮抗剂、白细胞介素-1β和肿瘤坏死因子-α的常见变异与卵巢癌风险:一项病例对照研究。
Cent Eur J Immunol. 2017;42(2):150-155. doi: 10.5114/ceji.2017.69356. Epub 2017 Aug 8.
9
Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.骨形态发生蛋白通路在癌症中的新作用:激酶抑制的潜在治疗靶点。
Biochem Soc Trans. 2016 Aug 15;44(4):1117-34. doi: 10.1042/BST20160069.
10
Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.三种失调的 microRNA 控制卵巢癌中激肽释放酶 10 的表达和细胞增殖。
Br J Cancer. 2010 Apr 13;102(8):1244-53. doi: 10.1038/sj.bjc.6605634. Epub 2010 Mar 30.